Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
69 participants
INTERVENTIONAL
2015-09-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Direct Measurement of Ideal Depth of Central Line
NCT03116724
Adequate Insertion Depth of Dilator During Central Venous Catheterization
NCT04279808
A Difference in Subclavian Vein Catheterization Between Supine and Lateral Tilt Position - Stage II
NCT03303274
Effects of Different Intra-arterial Catheter Size on Frequency of Optimal Dynamic Response in Radial Arterial Waveform
NCT03642756
Needle Puncture Point During Central Venous Catheterization With Ultrasound Guidance
NCT04916288
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomly assigned to three group according to the depth of guide-wire prior to tissue dilation during central catheterization via right internal jugular vein. (Group 1: 15 cm / Group 2: 17.5 cm / Group 3: 20 cm)
Central catheterization will be performed by anesthesiologists who be blinded to this study protocol.
An investigator will monitor and record whether any arrhythmia will occur.
The incidence of occurrence of arrhythmia will be compared between three groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
15 cm
The depth of guide wire will be 15 cm from puncture site of skin prior to tissue dilation during central venous catheterization
central venous catheterization
15 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 15 cm.
17.5 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 17.5 cm.
20 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 20 cm.
17.5 cm
The depth of guide wire will be 17.5 cm from puncture site of skin prior to tissue dilation during central venous catheterization
central venous catheterization
15 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 15 cm.
17.5 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 17.5 cm.
20 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 20 cm.
20 cm
The depth of guide wire will be 20 cm from puncture site of skin prior to tissue dilation during central venous catheterization
central venous catheterization
15 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 15 cm.
17.5 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 17.5 cm.
20 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 20 cm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
central venous catheterization
15 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 15 cm.
17.5 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 17.5 cm.
20 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 20 cm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA (American Society of Anesthesiologist) physical status class I or II
Exclusion Criteria
* when monitoring before the induction of anesthesia in the operating room, newly arrhythmia is observed.
* abnormal electrolyte at the pre-anesthetic evaluation
* too difficult to access right internal jugular vein for central catheterization (too short neck, infection at the site of right internal jugular vein, ventriculoperitoneal shunt or chemo-port existence at the site of right internal jugular vein. too close site to operating field)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung-Man Lee
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jung-Man Lee, M.D.
Role: STUDY_DIRECTOR
Seoul National University Boramae Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Boramae Hospital
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-2015-105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.